Loading clinical trials...
Loading clinical trials...
The Effects of Intranasal Testosterone (NatestoTM) for Treatment of Hypogonadism on Maintenance of Spermatogenesis
Conditions
Interventions
NatestoTM
Locations
1
United States
University of Florida
Gainesville, Florida, United States
Start Date
June 1, 2022
Primary Completion Date
April 21, 2025
Completion Date
April 21, 2025
Last Updated
June 13, 2025
NCT06689085
NCT06841328
NCT03851627
NCT06094036
NCT04326673
NCT04558567
Lead Sponsor
University of Florida
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions